Saturday 17 October 2026 Export BIOX’s income statement to Excel — free account

Bioceres Crop Solutions Corp.

BIOX Basic Materials Agricultural Inputs

Bioceres Crop Solutions Corp.’s revenue for fiscal 2026 (year ended June 2026) was $238.2 million, down 28.6% from fiscal 2025. In the quarter to March 2026, revenue fell 34.7%, EPS fell 700.0%, free cash flow grew 344.3% and total debt fell 29.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

0.28 0.01 −3.45%

Follow BIOX

Alert me

Market cap: $18.6M
P/E: 0.0×
Fwd P/E: 27.0×
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 18.63%

Capital & Financial Ratios $m

Market Cap 18.58

Revenue 271.01

Net Income (51.66)

Free Cash Flow 78.53

Net Debt 105.60

Current Ratio 0.88

Debt/Equity 1.26

P/E ratio 0.00

Fwd P/E 27.00

P/S ratio 0.07

P/B ratio 0.17

Past 5Y EPS Growth —

This Y EPS Growth 80.48%

Next Y EPS Growth 117.05%

Next Y revenue growth 58.98%

Next 5Y EPS Growth 61.59%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.05%

10-year low 10-year high

P/B against its own 10 years 0.05%

10-year low 10-year high

EV/Sales against its own 10 years 0.05%

10-year low 10-year high

EV/FCF against its own 10 years 0.08%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2019	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	2026
Cash	60	56	35	12
Receivables	196	226	184	112
Inventory	141	126	90	47
Other	—	—	—	44
	397	409	308	215

	2023	2024	2025	2026
Payables	151	169	96	58
ST’ Debt	108	137	120	47
Other	11	12	8	34
	299	329	338	267

Compound Annual Growth %

	10y	5y	3y
Sales	—	2.60%	(16.94%)
Cash Flow	—	39.88%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	(6.62%)	(42.12%)

Revenue $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	77	74	39	—	238
’25	94	99	60	81	334
’24	117	139	84	122	462
’23	127	93	92	103	416
’22	67	93	69	106	335
’21	42	49	36	82	210

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	14	17	—	—	—
’25	5	(5)	23	27	50
’24	15	21	(17)	23	42
’23	(32)	41	2	(8)	3
’22	(14)	(6)	8	(5)	(18)
’21	(8)	(16)	(4)	21	(6)
’20	5	(5)	5	4	9

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	14	17	—	—	—
’25	4	(7)	21	27	44
’24	11	19	(20)	21	31
’23	(34)	39	(1)	(13)	(9)
’22	(15)	(7)	6	(3)	(19)
’21	(9)	(17)	(10)	20	(16)
’20	5	(5)	5	2	6

Fiscal quarters ending in the months shown.

EPS $

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	(0.12)	(2.88)	(0.16)	—	(0.86)
’25	(0.09)	0.00	(0.02)	(0.70)	(0.82)
’24	(0.04)	0.00	0.14	(0.03)	0.05
’23	0.01	(0.14)	0.45	(0.06)	0.26
’22	0.02	0.08	(0.16)	(0.12)	(0.17)
’21	(0.19)	0.02	(0.03)	0.02	(0.18)

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027e
Price, $
Price, $	Low	—	9.55	4.01	4.33	5.81	9.27	9.76	5.71	1.20	0.27	Analyst estimates 2027–2029 Powerpack
	High	—	10.68	10.15	7.24	17.94	16.00	14.20	14.05	7.44	1.56
People
People	Employees	—	—	409	447	497	565	790	983	751	—
	Revenue/emp, $m	—	0.00	0.39	0.39	0.42	0.59	0.53	0.47	0.44	0.00
Income, $m
Income, $m	Revenue	—	134	160	173	210	335	416	462	334	238
	Gross margin, %	—	42.27	45.76	45.94	43.38	37.76	43.36	39.83	39.02	34.76
	EBT	0	(25)	(9)	6	11	14	19	11	(58)	(51)
	EBT margin, %	0.00	(18.90)	(5.85)	3.72	5.03	4.20	4.60	2.39	(17.26)	(21.41)
	Net income	0	(14)	(16)	4	(4)	(4)	20	7	(59)	0
	Depreciation	0	4	5	5	6	9	19	21	22	—
Per share, $
Per share, $	Revenue	—	4.75	5.26	4.79	5.34	7.91	6.69	7.36	5.28	3.75
	Earnings	—	(0.01)	(0.73)	0.09	(0.18)	(0.17)	0.27	0.05	(0.82)	(0.86)
	Cash flow	0.00	0.65	0.97	0.26	(0.16)	(0.41)	0.04	0.66	0.79	0.00
	Capex	0.00	(0.12)	(0.08)	(0.09)	(0.25)	(0.04)	(0.19)	(0.17)	(0.09)	0.00
	Free cash flow	0.00	0.54	0.89	0.17	(0.41)	(0.46)	(0.15)	0.50	0.70	0.00
	Book value	0.00	1.18	2.04	1.68	2.30	3.74	5.32	5.59	4.67	1.01
	Shares, m	—	28	30	36	39	42	62	63	63	64
Valuation, ×
Valuation, ×	P/E	—	0.00	0.00	75.75	0.00	0.00	51.38	143.80	0.00	0.00
	P/S	—	0.00	1.00	1.26	2.63	1.73	2.00	1.51	0.85	0.08
	P/B	—	6.30	2.58	3.60	6.10	3.66	2.51	1.99	0.96	0.21
	EV/Sales	—	0.00	1.59	1.80	3.23	2.09	2.44	1.95	1.22	0.47
	EV/FCF	—	(37.52)	400.24	50.71	(42.56)	(36.19)	(111.57)	29.01	9.16	1.63
Cash, $m
Cash, $m	Operating cash flow	0	18	30	9	(6)	(18)	3	42	50	—
	Capex	0	(3)	(2)	(3)	(10)	(2)	(12)	(11)	(6)	—
	Free cash flow	0	15	27	6	(16)	(19)	(9)	31	44	—
Balance, $m
Balance, $m	Working capital	0	(33)	(18)	34	43	75	98	79	(30)	(52)
	Total debt	—	91	104	148	173	158	244	260	158	107
	Net debt	0	84	95	92	126	119	183	203	123	95
	Shareholders’ equity	0	33	62	61	90	158	330	351	295	64
Returns, %
Returns, %	ROA	0.00	(11.21)	(8.37)	1.24	(1.99)	(1.58)	2.81	0.51	(6.86)	(8.81)
	ROIC	0.00	8.37	12.73	16.02	11.08	8.98	6.59	5.16	(0.33)	(0.12)
	ROE	0.00	(66.61)	(38.58)	5.47	(9.10)	(5.79)	7.68	1.25	(17.14)	0.00

Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2026 · latest quarter Mar 2026 · fundamentals updated 2 Oct 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
IPI Intrepid Potash, Inc	$434.2M	16.2×	— (loss-making)	−1.26% (below 0%: shrinking)	+372.00% (above 0%: growing)	−31.61% (below 0%: shrinking)	24.97%	1.59%	Compare
AVD American Vanguard Corporation	$36.9M	— (loss-making)	11.4×	−9.71% (below 0%: shrinking)	n/m	−33.18% (below 0%: shrinking)	29.73%	(0.26%)	Compare
LVROF Lavoro Limited	$34.8M	— (loss-making)	— (loss-making)	−23.62% (below 0%: shrinking)	n/m	−6.85% (below 0%: shrinking)	15.65%	0.67%	Compare
BIOX Bioceres Crop Solutions Corp.	$18.6M	— (loss-making)	27.0×	−34.73% (below 0%: shrinking)	n/m	+344.29% (above 0%: growing)	32.23%	(10.91%)
SEED Origin Agritech Limited	$8.9M	— (loss-making)	— (loss-making)	+432.86% (above 0%: growing)	n/m	−107.51% (below 0%: shrinking)	22.38%	0.00%	Compare
ENFY Enlightify Inc.	$1.8M	— (loss-making)	—	−16.73% (below 0%: shrinking)	n/m	+48.84% (above 0%: growing)	23.90%	8.21%	Compare
BHILQ Benson Hill, Inc.	$1.5M	— (loss-making)	— (loss-making)	+45.32% (above 0%: growing)	n/m	+56.10% (above 0%: growing)	(1.34%)	(57.94%)	Compare
YTENQ Metabolix, Inc.	$1.5M	— (loss-making)	— (loss-making)	+305.41% (above 0%: growing)	n/m	+81.47% (above 0%: growing)	100.00%	(711.78%)	Compare
NXTS Nexentis Technologies Inc.	$990.0K	0.0×	— (loss-making)	−4,244.44% (below 0%: shrinking)	n/m	−2.86% (below 0%: shrinking)	100.00%	502.68%	Compare
Median of peers	$5.4M	—	—	−5.48%	—	−4.85%	24.44%	0.34%

All 18 Agricultural Inputs stocks →

Bioceres Crop Solutions Corp. (BIOX) key facts

Concern: Bioceres Crop Solutions Corp.’s revenue for fiscal 2026 (year ended June 2026) was $238.2 million, down 28.6% from fiscal 2025.
Bioceres Crop Solutions Corp. (BIOX) is an Agricultural Inputs company in the Basic Materials sector, listed on Nasdaq.
As of October 16, 2026, BIOX traded at $0.28, a market capitalization of $18.6 million.
Return on equity was 0.00% and debt-to-equity 1.26.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 2, 2026.